Recognizing this duality of effects may allow us to recommend treatment schedules such as one in which an AKAP10-focused genetic treatment to reduce cancer risk be delayed until after child-bearing years to avoid the increased risk of pre-term births. The gene discussed is AKAP10; the disease is cancer.